PRODUCT Properties
Melting point: | 123 °C |
Boiling point: | 377.3±17.0 °C(Predicted) |
Density | 1.394±0.06 g/cm3(Predicted) |
storage temp. | 2-8°C |
solubility | soluble in Methanol |
form | powder to crystal |
pka | 3.60±0.30(Predicted) |
color | White to Light yellow to Light orange |
InChI | InChI=1S/C9H7NO3/c11-9(12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H,11,12) |
InChIKey | BVSIAYQIMUUCRW-UHFFFAOYSA-N |
SMILES | O1C2=C(C=CC=C2)C(CC(O)=O)=N1 |
Description and Uses
1,??2-??Benzisoxazol-??3-??ylacetic Acid-13C2 is the labeled analogue of 1,??2-??Benzisoxazol-??3-??ylacetic Acid. 1,??2-??Benzisoxazol-??3-??ylacetic Acid-13C2 is an intermediate in the synthesis of Zonisamide-13C2-15N (Z700003), the labeled analogue of Zonisamide (Z700000), a sulfonamide antiseizure agent; blocks repetitive firing of voltagesensitive sodium channels and reduces voltage-sensitive T-type calcium currents. Heterocyclic methanesulfonide with anticonvulsant properties. The compound is under investigation for potential therapeutic use as an antiepileptic drug. Anticonvulsant.